Gravitas Medical has developed Entarik, an enteral nutrition intelligence platform that utilizes embedded sensors to collect over 140 gut data samples per second, ensuring accurate nasogastric tube placement. This technology enhances patient safety by enabling the early identification of life-threatening complications in enteral feeding, ultimately saving lives.
Funding
$9.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The incorrect placement of nasogastric tubes during enteral feeding can lead to life-threatening complications for patients. Traditional methods lack real-time feedback and can result in patient injury and delayed identification of critical issues.
Solution
Gravitas Medical's Entarik platform provides an enteral nutrition intelligence solution that enhances patient safety and simplifies enteral care. The platform utilizes embedded sensors within the nasogastric tube to collect over 140 gut data samples per second, providing real-time feedback on tube placement. This technology enables clinicians to confidently place NG Tubes, reduces the risk of patient injury, and facilitates the early identification of life-threatening complications associated with enteral feeding. By capturing and analyzing gastrointestinal data, Entarik aims to improve patient outcomes and streamline the enteral feeding process.
Target Audience
The primary target audience includes healthcare providers, hospitals, and clinicians involved in enteral feeding, particularly those in critical care and neonatal intensive care units (NICUs).
Features
- Embedded sensors in nasogastric tubes collect over 140 gut data samples per second.
- Real-time feedback on nasogastric tube placement.
- Clinical study demonstrating 100% accuracy of nasogastric tube placement.
- Designed to scale for early identification of complications in ICU patients.